Reaction

Juvenile Chronic Myelomonocytic Leukaemia reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 49 reports · 2 co-occurring drugs

As of the last recalculation, Juvenile Chronic Myelomonocytic Leukaemia appears in 49 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is FLUDARABINE PHOSPHATE (PRR 364.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Fludarabine Phosphate	20	364.4	364.6
Azacitidine For	9	257.2	257.4

Related reactions

Drug Ineffective
Off Label Use
Death
Nausea
Fatigue

Data source: openFDA FAERS. See the OpenPV methodology and limitations.